Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

By Fernández-Sánchez Mónica   Gamboa-Dominguez Armando   Uribe Norma   García-Ulloa Ana   Flores-Estrada Diana   Candelaria Myrna   Arrieta Oscar  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 171-183

Humana Press, Inc

Access to resources Recommend Favorite

Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [ 18 F]-fluorodeoxyglucose positron emission tomography

By Burcombe R.J.   Makris A.   Pittam M.   Lowe J.   Emmott J.   Wong W.L.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 375-379

Elsevier

Access to resources Recommend Favorite

Clinical and Pathological Response to Primary Chemotherapy in Operable Breast Cancer

By Chollet P.   Charrier S.   Brain E.   Cure H.   van Praagh I.   Feillel V.   de Latour M.   Dauplat J.   Misset J.-L.   Ferriere J.-P.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 862-866

Elsevier

Access to resources Recommend Favorite

Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer

By Keam Bhumsuk   Im Seock-Ah   Lim Yoojoo   Han Sae-Won   Moon Hyeong-Gon   Oh Do-Youn   Cho Nariya   Lee Se-Hoon   Han Wonshik   Moon Woo   Kim Dong-Wan   Kim Tae-You   Park In   Noh Dong-Young  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2242-2249

Springer Publishing Company

Access to resources Recommend Favorite

Progress in Evaluation of Pathologic Response to Neoadjuvant Chemotherapy of Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 2, 2013-02 ,pp. : 222-226

Bentham Science Publishers

Access to resources Recommend Favorite